Condition: Myelofibrosis (MF) · Sponsor: iOnctura
The goal of this clinical trial is to learn how roginolisib works in comparison to standard treatment in adult patients with Myelofibrosis. The main questions it aims to answer is to evaluate the safety and tolerability of roginolisib when administered in combination with ruxolitinib.
This description comes directly from the study's public registry record.
Tracey Hammett, RN · +44 7776498978 · t.hammett@ionctura.com
Karen Tonge · +44 7770678446 · k.tonge@ionctura.com
Always discuss trial participation with your own doctor first.
| Azienda Ospedaliero Universitaria Careggi Firenze, Struttura Complessa di Ematologia | Florence, Florence, Italy | Recruiting |
| IRCCS Clinical Institute Humanitas | Rozzano, Milan, Italy | Recruiting |
| Istituto di Ematolgia e Oncologia Medica | Bologna, Italy | Recruiting |
| Istituto Romagnolo per lo Studio dei Tumori | Meldola, Italy | Recruiting |
| Azienda Sanitario Universitaria Friuli Centrale | Udine, Italy | Recruiting |
| Vall d'Hebron University Hospital | Barcelona, Spain | Recruiting |
| Avigunda Gran via de l'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat | Barcelona, Spain | Recruiting |
| START Madrid CIOCC | Madrid, Spain | Recruiting |
| Hospital Universitario de Salamanca | Salamanca, Spain | Recruiting |
| United Lincolnshire Teach Hospitals NHS Trust, Pilgrim Hospital Boston | Boston, Lincolnshire, United Kingdom | Recruiting |
| Belfast City Hospital | Belfast, United Kingdom | Recruiting |
| Guy´s and St. Thomas NHS Foundation Trust | London, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06887803